Novo Nordisk A/S (NVO)
50.25
+1.20
(+2.45%)
USD |
NYSE |
Dec 11, 13:47
Novo Nordisk Price: 50.25 for Dec. 11, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Evaxion AS | 6.45 |
| Ascendis Pharma A/S | 217.00 |
| Regeneron Pharmaceuticals, Inc. | 739.22 |
| Omeros Corp. | 10.54 |
| Viking Therapeutics, Inc. | 37.68 |
Price Related Metrics
| PE Ratio | 14.64 |
| PS Ratio | 4.794 |
| PEG Ratio | 1.293 |
| Price to Book Value | 11.01 |
| Price to Free Cash Flow | 24.21 |
| Earnings Yield | 6.83% |
| Market Cap | 223.28B |
| PEGY Ratio | 0.9863 |
| Operating PE Ratio | 11.30 |
| Normalized PE Ratio | 14.64 |